ASCs across the country are facing skyrocketing practice costs paired with declines in reimbursements from payers.
Patsy Newitt
Cardiology is one of the fastest-growing specialties for ASCs, and many leaders feel this growth will only accelerate as payers, investors and physicians realize the opportunities.
Here are seven stories involving colonoscopy or colorectal cancer treatment that Becker's as reported on since July 1:
Nashville, Tenn.-based HCA Healthcare saw outpatient surgery volume decline for the second consecutive quarter because of lower Medicaid and self-pay volumes, executives explained in a July 23 earnings call transcribed by Seeking Alpha.
Cardiology-specific ASCs are faced with new challenges as payers update policies amid these high-acuity procedures' migration to the outpatient setting.
Cardiology is one of the biggest opportunities for ASC growth as procedures are increasingly approved for the outpatient setting.
ASCs are a component of St. Louis-based Ascension plans for growth amid a $3 billion operating loss in fiscal 2023.
Optum, the country's largest employer of physicians and parent company of ASC chain SCA Health, has revealed plans to shutter several clinics so far in 2024.
A class action lawsuit has been filed against Portland-based Providence Health and Oregon Anesthesiology Group after one anesthesiologists alleged negligence led to potential hepatitis and HIV exposures, NBC affiliate KGW reported July 28.
ASC leaders and hospitals alike are facing major obstacles to profitability as operational costs soar and Medicare and private payer reimbursement rates sink.
